Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
Preferred Name | Pimozide | |
Synonyms |
|
|
Definitions |
A diphenylbutylpiperidine derivative and a dopamine antagonist with antipsychotic property. Pimozide selectively inhibits type 2 dopaminergic receptors in the central nervous system (CNS), thereby decreasing dopamine neurotransmission and reducing the occurrence of motor and vocal tics and delusions of parasitosis. In addition, this agent antagonizes alpha-adrenergic and 5-HT2 receptors. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C47672 |
|
CAS_Registry |
2062-78-4
|
|
CHEBI_ID |
CHEBI:8212
|
|
Chemical_Formula |
C28H29F2N3O
|
|
code |
C47672
|
|
Contributing_Source |
CTRP FDA
|
|
definition |
A diphenylbutylpiperidine derivative and a dopamine antagonist with antipsychotic property. Pimozide selectively inhibits type 2 dopaminergic receptors in the central nervous system (CNS), thereby decreasing dopamine neurotransmission and reducing the occurrence of motor and vocal tics and delusions of parasitosis. In addition, this agent antagonizes alpha-adrenergic and 5-HT2 receptors.
|
|
Display_Name |
Pimozide
|
|
FDA_UNII_Code |
1HIZ4DL86F
|
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Pimozide
|
|
Legacy Concept Name |
Pimozide
|
|
NSC Number |
170984
|
|
Preferred_Name |
Pimozide
|
|
prefixIRI |
NCIT:C47672
|
|
prefLabel |
Pimozide
|
|
Semantic_Type |
Pharmacologic Substance
|
|
UMLS_CUI |
C0031935
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping